Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer?
|
|
- Abner Booker
- 5 years ago
- Views:
Transcription
1 Endothelium as a part of septic Multiple Organ Dysfunction Syndrome (MODS)-is endocan an answer? Małgorzata Lipinska-Gediga Department of Anaesthesiology and Intensive Therapy Medical University Wroclaw, Poland
2 Sepsis is a systemic, deleterious host response to infection leading to severe sepsis (acute organ dysfunction secondary to documented or suspected infection) and septic shock (severe sepsis plus hypotension not reversed with fluid resuscitation) Intensive Care Med (2013) 39: DOI /s
3 Under resting conditions, endothelial cells exhibit a number of important physiological functions : regulate blood pressure and blood flow by modulating the tone of arterioles inhibit blood coagulation express thrombomodulin, which binds thrombin and Activated protein C (APC), with its cofactor protein S, blocks the cofactors VIIIa and Va of the clotting system. release small amount of tissue-type plasminogen activator and inhibit platelet aggregation by producing prostacyclin and nitric oxide regulate the transmigration of leukocytes by controlling the expression of adhesion molecules and the production of chemoattractants
4 As one of the largest organs, the endothelial and capillary system occupies a central role in the homeostasis of organ functions. However, one of the largest and most important organs, is not routinely tracked in the daily clinical routine In sepsis, endothelial activation and dysfunction are critical determinants of the host response and represent an explanation for the complex sepsis pathophysiology ( Iba et al. 2005; Shapiro et al. 2010,Paulus 2011).Given this central place of the endothelium, there is a strong biologic rationale for targeting markers of endothelial activation as biomarkers of sepsis. (Pierrakos and Vincent 2010, Paulus 2011, Xing 2012, De Backer 2014).
5
6 N Engl J Med 363;7 nejm.org August 12, 2010
7
8 Endocan, also called endothelial cell-specific molecule-1, is a soluble 50 kda dermatan sulfate proteoglycan that is secreted from pulmonary and kidney vascular endothelial cells [Bechard et al. 2001, Lassalle et al.1996]. Endocan is stable at low levels in the blood and was detected in the serum of healthy subjects at an average concentration of 1.08 ng/ml. ESM-1 mrna is regulated by the cytokines, TNFα induced accumulation of ESM-1 mrna early;(berchard et al. 2000), it was detectable at the second hour and peaked at the 18th hour of TNF incubation. The spontaneous as well as TNFα-induced secretion of ESM-1 is strongly inhibited by IFNγ. Endocan was shown to inhibit the interaction between intercellular adhesion molecule-1 (ICAM-1) and the integrin (lymphocyte functionassociated antigen-1) LFA-1 on leukocytes, and can modulate LFA-1 mediated leukocyte functions, such as the firm adhesion of leukocytes to the endothelium and the leukocytes transmigration (Bechard et al. 2000)
9 Study group comprised twenty two patients with septic shock, admitted to the Department of Anesthesiology and Intensive Therapy of Wroclaw Medical University, Poland. Patients with cardiogenic shock and other acute circulatory failure not induced by infection were excluded from the study. The study group patients were retrospectively divided into the survivors (n = 15) and non-survivors (n = 7) subgroups. The diagnosis of septic shock was performed according to the 2001 Consensus Conference Criteria.This study is observational and prospective. The status of clinical patients was assessed with the Acute Physiology and Chronic Health Evaluation II (APACHE II) score [Knaus et al. 1985] on admission to the ICU, and the extent of multiple organ failure was evaluated using the Sequential Organ Failure Assessment (SOFA) score [Vincent et al.1996] on admission, and on the 2nd, 3rd, and 5th days. Blood was drawn on admission, and on the 2nd, 3rd, and 5th days.
10
11 Control group-adult patients undergoing valve replacement or coronary artery bypass grafting under cardiopulmonary bypass (ECC) were consecutively included in the study. Endocan levels were measured before and directly after surgery, next on the 1st and 2nd postoperative day at the ICU. The control group consisted of 19 patients (12 men, 7 women, mean age 67 years), this group presented no multiple organ failure in postoperative period and the ICU stay didn t exceed 2 days. Cardio (ECC) group n=19 Septic group n=22 P value Endocan 1st 2,10 (0,64 7,9) 5,25 (0,58 13,0) 0,0009 Endocan 2nd 5,06 (0,97 6,9) 5,09 (0,58 12,0) 0,24 Endocan 3rd 4,80 (1,09 11,0) 2,36 (0,65 10,0) 0,08 Endocan 4th 3,1 (1,0 10,7) 2,01 (0,58 12,0) 0,68
12 APACHE II and SOFA score in septic shock group Survivors N=15 Non-survivors N=7 P value APACHE II 1st day 21,5 ± 5,41 28,66± 7,36 0,025 SOFA 1st day 10,85 ± 2,53 13,66 ± 3,07 0,048 SOFA 2nd day 8,14 ± 1,87 12,16 ± 3,18 0,002 SOFA 3rd day 6,07 ±3,19 11,00 ± 6,27 0,04 SOFA 5th day 4,33 ± 3,04 12,00 ± 5,29 0,009 Endocan (ng/ml) in septic shock group Survivors N=15 Non-survivors N=7 P value Endocan 1st day 4,46 (0,58 9,57) 7,15 (2,8 13,0) 0,13 Endocan 2nd day 5,34 (0,58 10,8) 4,85 (2,6 12,0) 0,52 Endocan 3rd day 2,26 (0,65 10,0) 4,0 (2,34 10,0) 0,19 Endocan 5th day 1,76 (0,58 8,00) 10,8 (1,56 12,0) 0,03
13 Cardio (ECC) group n=19 Septic survivors n=15 P value Endocan 1st 2,10 (0,64 7,9) 4,46 (0,58 9,57) 0,006 Endocan 2nd 5,06 (0,97 6,9) 5,34 (0,58 10,8) 0,6 Endocan 3rd 4,80 (1,09 11,0) 2,26 (0,65 10,0) 0,005 Endocan 4th 3,1 (1,0 10,7) 1,76 (0,58 8,00) 0,25 Cardio (ECC) group Septic non-survivors P value n=19 n=7 Endocan 1st 2,10 (0,64 7,9) 7,15 (2,8 13,0) 0,002 Endocan 2nd 5,06 (0,97 6,9) 4,85 (2,6 12,0) 0,38 Endocan 3rd 4,80 (1,09 11,0) 4,0 (2,34 10,0) 0,88 Endocan 4th 3,1 (1,0 10,7) 10,8 (1,56 12,0) 0,20
14 Procalcitonin (PCT) is a prohormone of calcitonin consisting of 114 to 116 amino acid, PCT originates from the calcitonin-i (CALC-I) gene on chromosome 11.Under physiological conditions serum levels are below 0.5 ng/ml. A microbial infection induces an ubiquitous increase in CALC-I gene expression and a significant release of CTpr from all tissues and cell types (Müller, 2001 ). Whang and et. al considers that PCT is a secondary mediator intensifying, rather than initiating, the septic response (Whang, 2000). According to SSCIG 2013 (Dellinger 2013) PCT is used as a diagnostic marker of sepsis, monitoring its course and therapeutical efficacy.
15 Correlation between the procalcitonin (PCT) and endocan levels o admission in septic survivors group PCT [ng g/ml] r = 0,535, p=0, Endocan [ng/ml]
16 WBC [10 9 /L] Correlation between the endocan and WBC on 2-nd day after research in septic survivors group r = 0,577, p=0, Endocan [ng/ml]
17 Based on the preliminary results, the serum endocan is usually only slightly induced in the course of the time-limited inflammatory response (cardiac surgery) The highest values of endocan were observed in non-survivors (n=7) and was directly associated with the highest APACHE II and SOFA score results, reflecting the clinical status and progress of multiple organ failure in this group Prognostic value? Correlations? The research is ongoing
The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya
The Usefulness of Sepsis Biomarkers Dr Vineya Rai Department of Anesthesiology University of Malaya 1 What is Sepsis? Whole Body Inflammatory State + Infection 2 Incidence and Burden of Sepsis in US In
L utilizzo della Procalcitonina in Medicina d Urgenza
L utilizzo della Procalcitonina in Medicina d Urgenza Stefania Battista Dirigente Medico S.C. Medicina d Urgenza Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino Savona, 15 ottobre 2009
SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX?
SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX? Sir Ganga Ram Hospital New Delhi, India Dr. Seema Bhargava Senior Consultant & Chairperson Department of Biochemistry & Professor, GRIPMER Sir
Pathophysiology of Catheter-Related Infection. All sources of infection are potential targets for prevention. Infusates/ drugs. hub/lines Dressing
Pathophysiology of Catheter-Related Infection All sources of infection are potential targets for prevention catheter hematogeneous Infusates/ drugs hub/lines Dressing skin Critically ill patient: 2-4 vascular
What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health
What the ED clinician needs to know about SEPSIS - 3 Anna Morgan Consultant EM Barts Health Aims: (1) To review the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (2)
Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis
Thursday 11 th June 2015 Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis Dr Duncan Wyncoll Guy s & St Thomas NHS Trust, London Conflicts of Interest In
Disclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice
Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal
The Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
OHSU. Update in Sepsis
Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin
Biomarkers in sepsis. Dr S Omar University of Witwatersrand CHBAH Bara ICU
Biomarkers in sepsis Dr S Omar University of Witwatersrand CHBAH Bara ICU Procalcitonin PCT biomarker 1993- described as a sepsis associated protein Identical to the precursor protein of calcitonin which
Basic immunology. Lecture 9. Innate immunity: inflammation, leukocyte migration. Péter Engelmann
Basic immunology Lecture 9. Innate immunity: inflammation, leukocyte migration Péter Engelmann Different levels of the immune response Recognition molecules of innate immunity Initiation of local and systemic
The Use of Metabolic Resuscitation in Sepsis
The Use of Metabolic Resuscitation in Sepsis Jennifer M. Roth, PharmD, BCPS, BCCCP Critical Care Clinical Specialist - Surgical Trauma ICU Baylor University Medical Center Disclosures No conflicts of interest
The recruitment of leukocytes and plasma proteins from the blood to sites of infection and tissue injury is called inflammation
The migration of a particular type of leukocyte into a restricted type of tissue, or a tissue with an ongoing infection or injury, is often called leukocyte homing, and the general process of leukocyte
Prognostic role of adrenomedullin in sepsis
Int. J. Adv. Res. Biol. Sci. (2016). 3(5): 136-141 International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com Volume 3, Issue 5-2016 Research Article Prognostic role
Sepsis and Shock States
Sepsis and Shock States Presented By: Cynthia Webner BSN, RN, CCRN, CMC www.cardionursing.com CNEA 2009 1 INFECTION Inflammatory response to microorganisms, or Invasion of normally sterile tissues SYSTEMIC
Usefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
Sepsis and Multiple Organ Failure. J.G. van der Hoeven Radboud University Nijmegen Medical Centre
Sepsis and Multiple Organ Failure J.G. van der Hoeven Radboud University Nijmegen Medical Centre Sepsis - initiation Microorganism Tissue Damage Pathogen Associated Molecular Pattern (PAMP) Pattern Recognition
CASE SERIES IN POSTOPERATIVE CARDIAC SURGERY PATIENTS
2 nd International User Meeting October 2, 2015 Berlin Prof. Dr. Karl Träger Cardiosurgical ICU Dept. of Cardiac Anesthesiology University Hospital Ulm Albert-Einstein-Allee 23, 89081 Ulm GERMANY karl.traeger@uniklinik-ulm.de
4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures
Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare
Irreversible shock can defined as last phase of shock where despite correcting the initial insult leading to shock and restoring circulation there is
R. Siebert Irreversible shock can defined as last phase of shock where despite correcting the initial insult leading to shock and restoring circulation there is a progressive decline in blood pressure
BIOMARKERS IN SEPSIS
BIOMARKERS IN SEPSIS Dr. Syed Ghulam Mogni Mowla Assistant Professor, Medicine, DMC BSMCON 17 WHY WE NEED TO KNOW Sepsis and its complications are a common cause of infectious disease illness and mortality
Updates in Sepsis 2017
Mortality Cases Total U.S. Population/1,000 Updates in 2017 Joshua Solomon, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Background New Definition of New Trials
Pro-atrial natriuretic peptide (pro-anp) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance
Infection (2012) 40:303 309 DOI 10.1007/s15010-011-0235-0 CLINICAL AND EPIDEMIOLOGICAL STUDY Pro-atrial natriuretic peptide (pro-anp) level in patients with severe sepsis and septic shock: prognostic and
Sepsis Learning Collaborative: Sepsis New Definitions
Sepsis Learning Collaborative: Sepsis New Definitions Sepsis 3, a New Definition Todd L. Slesinger, MD, FACEP, FCCM, FCCP, FAAEM Program Director and Academic Chair Department of Emergency Medicine Disclosures
Shock, Hemorrhage and Thrombosis
Shock, Hemorrhage and Thrombosis 1 Shock Systemic hypoperfusion due to: Reduction in cardiac output Reduction in effective circulating blood volume Hypotension Impaired tissue perfusion Cellular hypoxia
Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment
Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus
La Trombosi Arteriosa
La Trombosi Arteriosa Prof. Giovanni Davì Medicina Interna Chieti Platelet activation and thrombosis Harrison 19 edizione Platelets are essential for primary hemostasis and repair of the endothelium They
Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign
Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated
5/1/2015 SEPSIS SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 INFECTION CAN BE CONFIRMED BY:
SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 Omer Nasiroglu MD Baptist Children s Hospital Pediatric Emergency Department SEPSIS IS A SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Use of procalcitonin assay to streamline antibiotic usage. Dr Kristine Luk
Use of procalcitonin assay to streamline antibiotic usage Dr Kristine Luk Outline Procalcitonin physiology & kinetics Limitations Different settings - primary care & AED - critically ill patients - neutropenic
Acute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
/////// Procalcitonin. Solutions for Emergency Diagnostics. A Novel Biomarker for Bacterial Infections and Sepsis. VIDAS Emergency Assays
/////// Solutions for Emergency Diagnostics 2015 BIOMÉRIEUX, INC. BIOMÉRIEUX, THE BLUE LOGO AND VIDAS ARE USED PENDING AND/OR REGISTERED TRADEMARKS BELONGING TO BIOMÉRIEUX SA OR ONE OF ITS SUBSIDIARIES
Use of Blood Lactate Measurements in the Critical Care Setting
Use of Blood Lactate Measurements in the Critical Care Setting John G Toffaletti, PhD Director of Blood Gas and Clinical Pediatric Labs Professor of Pathology Duke University Medical Center Chief, VAMC
A BRIEF HISTORY OF SEPSIS. Euan Mackay
A BRIEF HISTORY OF SEPSIS Euan Mackay Aims History of sepsis definition Validity of new definition Hippocrates 4 th century BC Hippocrates introduced the term "σήψις the process of decay or decomposition
Neue Wirkungsmechanismen von Transfusionsplasma
Neue Wirkungsmechanismen von Transfusionsplasma Lorenzo ALBERIO Médecin chef Hématologie générale et Hémostase Service et Laboratoire centrale d Hématologie CHUV, Lausanne Trauma patient Bleeding Thrombosis
Initial Resuscitation of Sepsis & Septic Shock
Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known
Increased female mortality after ICU admission and its potential causes.
Increased female mortality after ICU admission and its potential causes. L. Mardini, J. Lipes, D. Jayaraman McGill University CCCF 2012 Oral presentations session October 29 th 2012 Increased female mortality
Advancements in Sepsis
Objectives Advancements in Sepsis Brian Gilbert, PharmD PGY-1 Pharmacy Resident Jackson Memorial Hospital 3/13/2016 www.fshp.org Pharmacist objectives Review recent updates in resuscitation strategies
Research paper 45. Address: Department of Anaesthesiology, University of Erlangen-Nuremburg, Krankenhausstr. 12, D Erlangan, Germany.
Research paper 45 Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS Michael Meisner, Klaus Tschaikowsky,
INVESTIGATIONAL TREATMENTS FOR SEPSIS AN OVERVIEW
INVESTIGATIONAL TREATMENTS FOR SEPSIS AN OVERVIEW THE GLOBAL BURDEN OF SEPSIS Mortality rate estimated to be 30-50% Rates estimated to be as high as 80% in developing nations One third to one half of all
Cell-Derived Inflammatory Mediators
Cell-Derived Inflammatory Mediators Introduction about chemical mediators in inflammation Mediators may be Cellular mediators cell-produced or cell-secreted derived from circulating inactive precursors,
Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients
European Review for Medical and Pharmacological Sciences 2019; 23: 338-342 Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients
9/25/2017. Nothing to disclose
Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain
Nothing to disclose 9/25/2017
Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain
a new biomarker in sepsis management Lunch Symposium, ISICEM 2016
a new biomarker in sepsis management Lunch Symposium, ISICEM 2016 Heparin-Binding Protein - an early marker of sepsisinduced organ dysfunction Dr Adam Linder, Lund, Sweden Elevated plasma Heparin Binding
Postoperative hypothermia and patient outcomes after elective cardiac surgery
doi:10.1111/j.1365-2044.2011.06784.x ORIGINAL ARTICLE Postoperative hypothermia and patient outcomes after elective cardiac surgery D. Karalapillai, 1 D. Story, 2 G. K. Hart, 3,4 M. Bailey, 5 D. Pilcher,
Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial
Adsorbtion of Cytokines Early in Septic Shock: the ACESS trial Prof. Zsolt Molnár zsoltmolna@gmail.com Department of Anaesthesia and Intensive Care University of Szeged Hungary Pathophysiology Local insult
Interessenskonflikt. 1) Cytosorb Register Planung. 2) Studie Seraph Microbind: ExThera Medical. 3) Fan von Arbeitsgruppe PD Dr.
Interessenskonflikt 1) Cytosorb Register Planung 2) Studie Seraph Microbind: ExThera Medical 3) Fan von Arbeitsgruppe PD Dr. David, MHH Cytokinelimination bei Sepsis JanT Kielstein Braunschweig Cytokinelimination
Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
BLOOD COAGULATION AND INFLAMMATION IN SEPSIS. A NEW CHALLENGE. Antonio Artigas Critical Center Sabadell Hospital Autonomous University of Barcelona
BLOOD COAGULATION AND INFLAMMATION IN SEPSIS. A NEW THINKING AND THERAPEUTIC CHALLENGE Antonio Artigas Critical Center Sabadell Hospital Autonomous University of Barcelona SEVERE SEPSIS PATHOPHYSIOLOGY
Chapter 3, Part A (Pages 37-45): Leukocyte Migration into Tissues
Allergy and Immunology Review Corner: Chapter 3, Part A (pages 37-45) of Cellular and Molecular Immunology (Seventh Edition), by Abul K. Abbas, Andrew H. Lichtman and Shiv Pillai. Chapter 3, Part A (Pages
Sepsis Pathophysiology
Sepsis Pathophysiology How Kids Differ From Adults Steve Standage Pediatric Critical Care Medicine Seattle Children's Hospital University of Washington School of Medicine Disclosures & Preamble No agenda,
Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components
Objectives Transfusion Pitfalls Gregory W. Hendey, MD, FACEP Professor and Chief UCSF Fresno, Emergency Medicine To list risks and benefits of various blood products To discuss controversy over liberal
Importance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery
Importance of kinetics of procalcitonin in septic patients János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery Host pathogen interactions the innate and the adaptive
Novel Sepsis Therapies
RSEM-GSA 17 Novel Sepsis Therapies Khaled Ahmed Alghamdi, MD, ABEM, FACEP, FAAEM Consultant Emergency Medicine Deputy program director Medical Director of Emergency Medical Services King Faisal Specialist
Controversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy
Controversies in Hospital Medicine: Critical Care Vasopressors, Steroids, and Insulin Therapy Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado Denver Clinical Specialist in Critical
JAMA. 2016;315(8): doi: /jama
JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287 SEPSIS 3 life-threatening organ dysfunction caused by a dysregulated host response to infection organ dysfunction: an increase in the SOFA
ESCMID Online Lecture Library. by author
What room for biomarkers in the management of anti-infective therapy Philippe Montravers Hôpital Bichat-Claude Bernard, Pole SUPRA APHP UFR Paris Diderot, Paris 7, Paris Cité Sorbonne Disclosures Speaker
1) Mononuclear phagocytes : 2) Regarding acute inflammation : 3) The epithelioid cells of follicular granulomas are :
Pathology Second 1) Mononuclear phagocytes : - Are the predominant cells in three day old wounds - Are common in liver, spleen and pancreasd - Produce fibroblast growth factor - Secrete interferon-g -
PCT-assisted antibiotic therapy
PCT-assisted antibiotic therapy Prof. Zsolt Molnár zsoltmolna@gmail.com Department of Anaesthesia and Intensive Care University of Szeged Hungary Problems with the definition of sepsis Definitive diagnoses
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to
Transfusion for the sickest ICU patients: Are there unanswered questions?
Transfusion for the sickest ICU patients: Are there unanswered questions? Tim Walsh Professor of Critical Care Edinburgh University None Conflict of Interest Guidelines on the management of anaemia and
Overview of effects of alcohol intake on cardiovascular disease
Beverage specific effects Overview of effects of alcohol intake on cardiovascular disease Dr. Ramon Estruch Department of Internal Medicine, Barcelona University, Spain. CIBER OBN Institute of Health Carlos
BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency
BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency Medicine 1 NO CONFLICT OF INTEREST 2 We do not fully understand
Septic AKI in ICU patients
Septic AKI in ICU patients Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum Berlin, Germany achim.joerres@charite.de Agenda Epidemiology
Part IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
Biomarkers for streamlining of Antibiotics in patients with severe infection.
Biomarkers for streamlining of Antibiotics in patients with severe infection. Philipp Schuetz, MD Feb, 2013 Email: Schuetzph@gmail.com You see this patient in your ICU -3d: Cough, Dyspnoe, Sputum T: 38.8
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes Richard Beale RIFLE classification (ADQI group) 2004 Outcome AKIN classification Definition: Abrupt (within 48 hrs)
Intraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
(Peripheral) Temperature and microcirculation
(Peripheral) Temperature and microcirculation Prof. Jan Bakker MD, PhD Chair dept Intensive Care Adults jan.bakker@erasmusmc.nl www.intensivecare.me Intensive Care Med (2005) 31:1316 1326 DOI 10.1007/s00134-005-2790-2
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,
Neuronal guidance protein semaphorin 7A influences neutrophil arrest and aggravates inflammatory lung injury. Dr. Tiago Granja
Neuronal guidance protein semaphorin 7A influences neutrophil arrest and aggravates inflammatory lung injury Dr. Tiago Granja Neuronal guidance proteins (NGPs) force cells to move NPGs give axons and dendrites
DEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University
DEMYSTIFYING VADs Nicolle Choquette RN MN Athabasca University Objectives odefine o Heart Failure o VAD o o o o Post Operative Complications Acute Long Term Nursing Interventions What is Heart Failure?
Procalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017
Procalcitonin YUKON KUSKOKWIM HEALTH CORPORATION PRESENTED BY: CURT BUCHHOLZ, MD AUGUST 2017 Procalcitonin (PCT) PCT isbeing studied as a biomarker for infection PCT consists of 116 amino
Urinary biomarkers in acute kidney injury. Max Bell MD, PhD Karolinska University Hospital Solna/Karolinska Institutet
Urinary biomarkers in acute kidney injury Max Bell MD, PhD Karolinska University Hospital Solna/Karolinska Institutet Development of AKI-biomarkers Early markers of AKI, do we need them? GFR drop Normal
Staging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children?
Radboud University Nijmegen Medical Centre Why measure cardiac output in critically ill children? J. Lemson Anesthesiologist/(pediatric)intensivist Case; Girl 2 years, 12 kg, severe meningococcal septic
Systemic inflammation after myocardial infarction
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2013 Systemic inflammation after myocardial infarction Rudiger, Alain DOI:
Assessing thrombocytopenia in the intensive care unit: The past, present, and future
Assessing thrombocytopenia in the intensive care unit: The past, present, and future Ryan Zarychanski MD MSc FRCPC Sections of Critical Care and of Hematology, University of Manitoba Disclosures FINANCIAL
Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma
Chapt. 45 Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma Inheritance of X-linked gene for Factor VIII hemophilia A Explain the
Classification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy
Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial
Resuscitation Symposium Resuscitation Literature Update. Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH
Resuscitation Symposium Resuscitation Literature Update Abdullah Al Reesi, MD, MSc, FACEP, FRCPC Sr. Consultant and HoD SQUH Objectives Review recent articles in sepsis New sepsis definition High versus
25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
Procalcitonin kinetics guided antibiotic management of the critically ill patient
Procalcitonin kinetics guided antibiotic management of the critically ill patient András LOVAS MD, PhD, EDIC, EDAIC University of Szeged, Hungary Department of Anaesthesiology and Intensive Therapy 19/11/2016,
Copyright 2010 Pearson Education, Inc. Blood Vessel Structure
Blood Vessel Structure Structure of Blood Vessel Walls Arteries and veins Tunica intima, tunica media, and tunica externa Lumen Central blood-containing space Capillaries Endothelium with sparse basal
Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID
Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage
Pathophysiology. Tutorial 3 Hemodynamic Disorders
Pathophysiology Tutorial 3 Hemodynamic Disorders ILOs Recall different causes of thrombosis. Explain different types of embolism and their predisposing factors. Differentiate between hemorrhage types.
Blood transfusions in sepsis, the elderly and patients with TBI
Blood transfusions in sepsis, the elderly and patients with TBI Shabbir Alekar MICU, CH Baragwanath Academic Hospital & The University of the Witwatersrand CCSSA Congress 11 June 2015 Packed RBC - complications
Clinical Guide to Use of PROCALCITONIN. for Diagnosis and PCT-Guided Antibiotic Therapy
Clinical Guide to Use of PROCALCITONIN for Diagnosis and PCT-Guided Antibiotic Therapy The content of this booklet was kindly written by: Philipp Schuetz, MD, MPH Privat Dozent for Endocrinology and Internal
International Journal of Advanced Research in Biological Sciences ISSN : Research Article
International Journal of Advanced Research in Biological Sciences ISSN : 2348-8069 www.ijarbs.com Research Article Serum level of IL-6, IL-10 and PCT as a prognostic marker in post traumatic sepsis patients.
Hemostasis and Thrombosis
Hemostasis Hemostasis and Thrombosis Normal hemostasis is a consequence of tightly regulated processes that maintain blood in a fluid state in normal vessels, yet also permit the rapid formation of a hemostatic
Evidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
Evaluation of Serum Lactate as Predictor of Morbidity and Mortality in Sepsis and Trauma Cases
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-38, p-issn:2319-7676. Volume 12, Issue 3 Ver. VII (May June 217), PP 1-5 www.iosrjournals.org Evaluation of Serum Lactate as Predictor
Early Recognition and Timely Management of Sepsis Amid Changes in Definitions
Early Recognition and Timely Management of Sepsis Amid Changes in Definitions Tze Shien Lo, MD, FACP Chief, Infectious Disease Service Fargo VA Medical Center Professor of Medicine UND School of Medicine
Unit 10 Cardiovascular System
Unit 10 Cardiovascular System I. Functions Deliver nutrients to cells > O 2, sugars, amino acids, lipids, ions, H 2 O... Remove waste from cells > CO 2, pathogens, toxins, lactic acid... Fight off infection
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
6/29/2017. Role of Biomarkers in the Management of Heart Failure Patients. What s New in Biomarkers for HF Patients?
What s New in Biomarkers for HF Patients? Role of Biomarkers in the Management of Heart Failure Patients Lori B. Daniels, MD, MAS, FACC Professor of Medicine Director, Cardiovascular Intensive Care Unit